Narrative review / 2019
Current evidence is insufficient to support using beans as a natural therapy for Parkinson's disease.
This review assesses the current knowledge regarding the use of various beans and their compounds (such as L-DOPA in Mucuna pruriens, broad beans, common beans, and soybeans) in Parkinson's disease (PD). Although animal models show neuroprotective effects and some human studies note improved motor performance after bean extracts, multiple concerns exist. These include poor translation from animal models, presence of potentially harmful bioactive ingredients at high doses, scarce human studies limited to single doses or short timeframes, and a total lack of long-term efficacy or side-effect data.
- Study type
- Critical narrative review
- Who was studied
- Patients with Parkinson's disease and animal models
- What was measured
- Motor performance, neuroprotection, and long-term efficacy/safety of bean intake
THE PAPER
Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models.
Rijntjes M. Parkinsons Dis, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.